Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

ADA’s Obesity Association Releases Guidelines for Use of Obesity Medications

ADA’s Obesity Association Releases Guidelines for Use of Obesity Medications

HCPLive 5 Stories in Under 5: Week of 01/04

HCPLive 5 Stories in Under 5: Week of 01/04

FDA Clears MiniMed Go Smart MDI App for Adults and Children with T1D, T2D

FDA Clears MiniMed Go Smart MDI App for Adults and Children with T1D, T2D

The HCPFive: Top News for Healthcare Providers from the Week of 01/04

The HCPFive: Top News for Healthcare Providers from the Week of 01/04

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Q4 2025 Recap: Endocrinology News and Updates

Q4 2025 Recap: Endocrinology News and Updates

Todays Updates

Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival Marco Meglio

Published phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Todays Updates

Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival Marco Meglio

Published phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Latest News

ADA’s Obesity Association Releases Guidelines for Use of Obesity Medications

HCPLive 5 Stories in Under 5: Week of 01/04

FDA Clears MiniMed Go Smart MDI App for Adults and Children with T1D, T2D

The HCPFive: Top News for Healthcare Providers from the Week of 01/04

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Q4 2025 Recap: Endocrinology News and Updates

News All Time

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

5 Endocrinology Headlines You Missed in November 2025

5 Endocrinology Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

Metformin Fails to Improve Insulin Resistance in Type 1 Diabetes

Metformin Fails to Improve Insulin Resistance in Type 1 Diabetes

Beyond Blood Sugar: Reframing Diabetes Awareness Through the Lens of Obesity

Beyond Blood Sugar: Reframing Diabetes Awareness Through the Lens of Obesity

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management

How painkillers can contribute to anemia in cancer patients

Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer ...

Keto diet associated with reduced depressive symptoms, anxiety results remain mixed

Researchers led by St Michael's Hospital in Toronto report that ketogenic diets are associated with modest reductions in depressive symptoms in adults, while evidence for anxiety remains uncertain.

Some women start menopause after surgery or medical treatment: Here's how it's different

For most women, menopause occurs naturally around the age of 49. In the lead up to menopause, the quality and quantity of eggs declines over time. Then the ovaries stop releasing eggs completely.

Evidence builds for disrupted mitochondria as cause of Parkinson's

For decades, scientists have known that mitochondria, which produce energy inside our cells, malfunction in Parkinson's disease. But a critical question remained: do the failing mitochondria cause Parkinson's, or do they ...

Study reveals how uterine contractions are regulated by stretch and pressure during childbirth

When labor begins, the uterus must coordinate rhythmic, well-timed contractions to deliver the baby safely. While hormones such as progesterone and oxytocin are key contributors to that process, scientists have long suspected ...

Can't take hormone therapy for menopause? There are other options

Shilpa Gajarawala struggled with hot flashes, night sweats, sleep problems and brain fog. But given her history of breast cancer, treating these menopausal symptoms with hormone therapy wasn't an option.

FDA lifts major warnings on hormone replacement therapy

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

Recommended News For You

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

June 20, 2023, Health Bulletin No. 12.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

Daily physical activity, even at light intensities, linked to lower cancer risk

Recommended Articles For You

Understanding Iron Saturation Levels in Your Blood  

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes 

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology 

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study sheds light on challenges for women of color after breast cancer surgery

2.

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

3.

FDA Approves CAR-T Product Use for Myeloma Early.

4.

How 7,000 steps a day could help reduce your risk of cancer

5.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

1.

Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes

2.

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia

3.

Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions

4.

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review

5.

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

2.

Navigating the Complexities of Ph Negative ALL - Part VII

3.

Updates on Standard V/S High Risk Myeloma Treatment

4.

Oropharyngeal Cancer in Relation to HPV Status

5.

Efficient Management of First line ALK-rearranged NSCLC - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot